University of Utah: Heart Failure trials
The registry lists 10 Heart Failure studies with University of Utah as lead sponsor. 1 are open to participants now and 2 have results posted.
Early Phase 1 1Phase 1 2Phase 2 2Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart DiseaseRecruitingNCT01099982
- Interleukin-1 Receptor Antagonist for the Treatment of Heart Failure in Patients With Left Ventricular Assist DevicesCompletedNCT02547766Phase 1/2Results posted
- Myocardial Hemodynamic Effects of LevosimendanCompletedNCT00585104Phase 2Results posted
- Muscle Afferent Feedback Effects in Patients With Heart FailureCompletedNCT01919918Phase 1
- Tissue Factor Expression in Stage C Heart FailureCompletedNCT00935740
- Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart FailureCompletedNCT00802230Phase 4
- The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart FailureCompletedNCT00769210Early Phase 1
- The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol TreatmentCompletedNCT00585091Not applicable
- CRT Pilot Study for Children With Heart FailureCompletedNCT00585065
- Angiotensin Converting Enzyme Inhibition in Children With Mitral RegurgitationTerminatedNCT00113698Phase 3